Long-term Antibiotic Therapy (Trimethoprim-sulfamethoxazole)

Type: drug

Status: FDA Approved (for general use)

Developer: Multiple pharmaceutical companies

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026